MD4434C1 - Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor - Google Patents
Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor Download PDFInfo
- Publication number
- MD4434C1 MD4434C1 MDA20150097A MD20150097A MD4434C1 MD 4434 C1 MD4434 C1 MD 4434C1 MD A20150097 A MDA20150097 A MD A20150097A MD 20150097 A MD20150097 A MD 20150097A MD 4434 C1 MD4434 C1 MD 4434C1
- Authority
- MD
- Moldova
- Prior art keywords
- myeloid leukemia
- human myeloid
- carbothiohydrazide
- ethylidene
- pyridyl
- Prior art date
Links
- 208000025113 myeloid leukemia Diseases 0.000 title claims abstract description 17
- 239000003112 inhibitor Substances 0.000 title claims abstract description 10
- FIGPFUPBRRMVLZ-UHFFFAOYSA-N n-(1-pyridin-2-ylethylideneamino)morpholine-4-carbothioamide Chemical compound C=1C=CC=NC=1C(C)=NNC(=S)N1CCOCC1 FIGPFUPBRRMVLZ-UHFFFAOYSA-N 0.000 title claims abstract description 8
- 230000004663 cell proliferation Effects 0.000 title claims abstract 4
- 150000001875 compounds Chemical class 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 150000002894 organic compounds Chemical class 0.000 abstract description 4
- 230000001085 cytostatic effect Effects 0.000 abstract description 3
- 238000011282 treatment Methods 0.000 abstract description 3
- 229940042396 direct acting antivirals thiosemicarbazones Drugs 0.000 abstract description 2
- 150000003584 thiosemicarbazones Chemical class 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- FGHSTPNOXKDLKU-UHFFFAOYSA-N nitric acid;hydrate Chemical compound O.O[N+]([O-])=O FGHSTPNOXKDLKU-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- RIFVPOHZBSIFRL-IZZDOVSWSA-N [(e)-1-pyridin-2-ylethylideneamino]thiourea Chemical compound NC(=S)N\N=C(/C)C1=CC=CC=N1 RIFVPOHZBSIFRL-IZZDOVSWSA-N 0.000 description 1
- FAWGZAFXDJGWBB-UHFFFAOYSA-N antimony(3+) Chemical class [Sb+3] FAWGZAFXDJGWBB-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003327 cancerostatic effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- -1 organic compound N'-[1-(2-pyridyl)ethylidene]morpholine-4-carbothiohydrazide Chemical class 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 150000007659 semicarbazones Chemical class 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Invenţia se referă la chimie şi medicină, şi anume la utilizarea unui compus organic din clasa tiosemicarbazonelor în calitate de inhibitor al proliferării celulelor HL-60 ale leucemiei mieloide umane şi poate găsi aplicare în medicină la profilaxia şi tratarea leucozelor. The invention relates to chemistry and medicine, namely to the use of an organic compound from the class of thiosemicarbazones as an inhibitor of the proliferation of HL-60 cells of human myeloid leukemia and may find application in medicine for the prophylaxis and treatment of leukosis.
Din compuşii chimici, care conţin în componenţa sa fragmentul tiosemicarbazidic, care inhibă leucemia mieloidă umană, descrişi în literatură, cel mai înalt efect cancerostatic a fost obţinut în cazul hidratului nitrat de saliciliden-4-feniltiosemicarbazido(1-)aquacupru(2+) [1] cu formula: Of the chemical compounds, which contain in its composition the thiosemicarbazido fragment, which inhibits human myeloid leukemia, described in the literature, the highest cancerostatic effect was obtained in the case of salicylidene-4-phenylthiosemicarbazido(1-)aquacopper(2+) nitrate hydrate [ 1] with the formula:
Complexul dat inhibă creşterea şi multiplicarea a 100% de celule HL-60 ale leucemiei mieloide umane la concentraţii de 10-5 şi 10-6 M. The given complex inhibits the growth and multiplication of 100% of HL-60 cells of human myeloid leukemia at concentrations of 10-5 and 10-6 M.
Dezavantajul hidratului nitrat de saliciliden-4-feniltiosemicarbazido(1-)-aquacupru(2+) constă în faptul că el nu posedă o activitate anticanceroasă suficient de înaltă şi nu inhibă proliferarea celulelor canceroase la o concentraţie mai mică de 10-6 mol/L. The disadvantage of salicylidene-4-phenylthiosemicarbazido(1-)-aquacopper(2+) nitrate hydrate is that it does not possess a sufficiently high anticancer activity and does not inhibit the proliferation of cancer cells at a concentration lower than 10-6 mol/L .
Este cunoscut compusul organic N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazida cu formula: The organic compound N'-[1-(2-pyridyl)ethylidene]morpholine-4-carbothiohydrazide with the formula:
Procedeul de sinteză a lui şi proprietăţile fizico-chimice sunt descrise în literatura ştiinţifică [2]. Totodată a fost stabilit că acest compus manifestă proprietăţi antimicrobiene, dar din cauza activităţii joase nu a găsit deocamdată aplicare în medicină. Its synthesis procedure and physico-chemical properties are described in the scientific literature [2]. At the same time, it was established that this compound exhibits antimicrobial properties, but due to its low activity, it has not yet found application in medicine.
Problema pe care o rezolvă prezenta invenţie este extinderea arsenalului de inhibitori ai proliferării celulelor HL-60 ale leucemiei mieloide umane cu activitate citostatică înaltă, inclusiv la concentraţii de 10-7 mol/L. The problem that the present invention solves is the expansion of the arsenal of inhibitors of the proliferation of HL-60 cells of human myeloid leukemia with high cytostatic activity, including at concentrations of 10-7 mol/L.
Esenţa invenţiei constă în utilizarea în calitate de inhibitor al proliferării celulelor HL-60 ale leucemiei mieloide umane a N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazidei. The essence of the invention consists in the use of N'-[1-(2-pyridyl)ethylidene]morpholine-4-carbothiohydrazide as an inhibitor of the proliferation of HL-60 cells of human myeloid leukemia.
Rezultatul tehnic al invenţiei constă în stabilirea la compusul dat a unei activităţi citostatice semnificative la concentraţii de 10-7 mol/L faţă de celulele HL-60 ale leucemiei mieloide umane. The technical result of the invention consists in establishing with the given compound a significant cytostatic activity at concentrations of 10-7 mol/L against HL-60 cells of human myeloid leukemia.
Rezultatul tehnic al invenţiei este condiţionat de faptul că pentru prima dată în calitate de inhibitor al proliferării celulelor HL-60 ale leucemiei mieloide umane se propune un compus organic, care conţine o combinaţie nouă de legături chimice deja cunoscute. The technical result of the invention is conditioned by the fact that for the first time an organic compound is proposed as an inhibitor of the proliferation of HL-60 cells of human myeloid leukemia, which contains a new combination of already known chemical bonds.
Exemplu de utilizare a N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazidei în calitate de inhibitor al leucemiei mieloide umane Example of use of N'-[1-(2-pyridyl)ethylidene]morpholine-4-carbothiohydrazide as an inhibitor of human myeloid leukemia
Celulele leucemiei mieloide umane HL-60 obţinute din Colecţia Americană a Culturilor Tip (American Type Culture Collection, Rockville, MD) au fost cultivate în formă de suspensie în mediul RPMI-1640 suplimentat cu 10% (V/V) ser embrionic de Sovine, 2 mM de L-glutamină, 100 UI penicilină/mL şi 100 µg de streptomicină/mL şi incubate în atmosferă umedă de 95% aer/5% CO2 la 37°C. Celulele au fost amestecate de 2…3 ori pe parcursul săptămânii, pentru a le păstra în fază omogenă. După aceasta celulele au fost plasate în vase Falcon din plastic pentru culturi cu 24 compartimente (2 cm2/celulă) la densitatea iniţială de 1·105 celule/mL/compartiment şi tratate cu soluţii de diferită concentraţie ale compusului revendicat în apă sterilă. Fiecare procedură de tratare cu aceeaşi concentraţie a fost efectuată în câte trei compartimente. Human myeloid leukemia HL-60 cells obtained from the American Type Culture Collection (Rockville, MD) were cultured in suspension in RPMI-1640 medium supplemented with 10% (V/V) fetal bovine serum, 2 mM L-glutamine, 100 IU penicillin/mL and 100 µg streptomycin/mL and incubated in a humid atmosphere of 95% air/5% CO2 at 37°C. The cells were mixed 2...3 times during the week to keep them in homogeneous phase. The cells were then placed in 24-compartment Falcon plastic culture dishes (2 cm 2 /cell) at the initial density of 1·10 5 cells/mL/compartment and treated with different concentration solutions of the claimed compound in sterile water. Each treatment procedure with the same concentration was performed in three compartments.
Datele experimentale obţinute privind studierea proprietăţilor anticanceroase ale N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazidei sunt prezentate în tabel, din care se observă că la o concentraţie de 10-5 mol/L se inhibă creşterea şi multiplicarea a 94,2%, la 10-6 mol/L - 82,85%, iar la o concentraţie de 10-7 mol/L - 77,1% de celule HL-60 ale leucemiei mieloide umane. Datele obţinute indică faptul că acest compus organic posedă o activitate anticanceroasă semnificativă la concentraţia de 10-7 mol/L, spre deosebire de analogul proxim, care este inactiv la această concentraţie. The experimental data obtained regarding the study of the anticancer properties of N'-[1-(2-pyridyl)ethylidene]morpholine-4-carbothiohydrazide are presented in the table, from which it is observed that at a concentration of 10-5 mol/L growth is inhibited and multiplication of 94.2%, at 10-6 mol/L - 82.85%, and at a concentration of 10-7 mol/L - 77.1% of HL-60 cells of human myeloid leukemia. The data obtained indicate that this organic compound possesses a significant anticancer activity at the concentration of 10-7 mol/L, unlike the close analogue, which is inactive at this concentration.
Proprietăţile depistate ale N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazidei prezintă interes pentru medicină din punct de vedere al extinderii arsenalului de inhibitori ai leucemiei mieloide umane. The detected properties of N'-[1-(2-pyridyl)ethylidene]morpholine-4-carbothiohydrazide are of interest for medicine from the point of view of expanding the arsenal of human myeloid leukemia inhibitors.
Tabel Table
Partea celulelor HL-60 ale leucemiei mieloide umane inhibate, % The fraction of inhibited human myeloid leukemia HL-60 cells, %
Compusul Concentraţie, mol/L 10-5 10-6 10-7 Hidratul nitrat de saliciliden-4-feniltiosemicarbazido(1-)aqua-cupru(2+) (analogul proxim) 100 100 0 N'-[1-(2-piridil)etiliden]morfolin-4-carbotiohidrazidă 94,2 82,85 77,1 Compound Concentration, mol/L 10-5 10-6 10-7 Salicylidene-4-phenylthiosemicarbazido(1-)aqua-copper(2+) nitrate hydrate (close analogue) 100 100 0 N'-[1-(2- pyridyl)ethylidene]morpholine-4-carbothiohydrazide 94.2 82.85 77.1
1. MD 3890 B1 2009.04.30 1. MD 3890 B1 2009.04.30
2. Kasuga N.C., Onodera K., Nakano S., Hazashi K., Nomiya K. Synthesis, crystal structures and antimicrobial activities of 6-coordinate antimony(III) complexes with tridentate 2-acetylpyridine thiosemicarbazone, bis(thiosemicarbazone) and semicarbazone ligands. J. Inorg. Biochem. 2006 July, 100, p. 1176-1186 DOI: 10.1016/j.inorbio.2006.01.037 2. Kasuga N.C., Onodera K., Nakano S., Hazashi K., Nomiya K. Synthesis, crystal structures and antimicrobial activities of 6-coordinate antimony(III) complexes with tridentate 2-acetylpyridine thiosemicarbazone, bis(thiosemicarbazone) and semicarbazone ligands . J. Inorg. Biochem. 2006 July, 100, p. 1176-1186 DOI: 10.1016/j.inorbio.2006.01.037
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20150097A MD4434C1 (en) | 2015-10-09 | 2015-10-09 | Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20150097A MD4434C1 (en) | 2015-10-09 | 2015-10-09 | Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4434B1 MD4434B1 (en) | 2016-09-30 |
| MD4434C1 true MD4434C1 (en) | 2017-04-30 |
Family
ID=57014936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20150097A MD4434C1 (en) | 2015-10-09 | 2015-10-09 | Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4434C1 (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985000955A1 (en) * | 1983-08-22 | 1985-03-14 | A/S Cheminova | A biocidal, particularly fungicidal and/or bactericidal composition and thiosemicarbazones and metal complexes thereof for use in the composition |
| US4596798A (en) * | 1982-03-30 | 1986-06-24 | The United States Of America As Represented By The Secretary Of The Army | 2-acetylpyridine thiosemicarbazones as antiviral agents |
| US5281715A (en) * | 1992-05-13 | 1994-01-25 | Yale University | 2-formylpyridine thiosemicarbazone compounds |
| US20030166658A1 (en) * | 2000-06-05 | 2003-09-04 | Johann Hofmann | Heterocyclic hydrazones for use as anti-cancer agents |
| MD3890G2 (en) * | 2008-09-08 | 2009-12-31 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia on base of coordinative compounds of copper(II) with salicylidene thiocarbazides |
| MD20110040A1 (en) * | 2011-05-10 | 2012-11-30 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate |
| MD4215C1 (en) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
| MD4393B1 (en) * | 2015-09-04 | 2016-01-31 | Universitatea De Stat Din Moldova | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper |
| MD4407B1 (en) * | 2015-04-29 | 2016-03-31 | Universitatea De Stat Din Moldova | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate |
-
2015
- 2015-10-09 MD MDA20150097A patent/MD4434C1/en not_active IP Right Cessation
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4596798A (en) * | 1982-03-30 | 1986-06-24 | The United States Of America As Represented By The Secretary Of The Army | 2-acetylpyridine thiosemicarbazones as antiviral agents |
| WO1985000955A1 (en) * | 1983-08-22 | 1985-03-14 | A/S Cheminova | A biocidal, particularly fungicidal and/or bactericidal composition and thiosemicarbazones and metal complexes thereof for use in the composition |
| US5281715A (en) * | 1992-05-13 | 1994-01-25 | Yale University | 2-formylpyridine thiosemicarbazone compounds |
| US5721259A (en) * | 1992-05-13 | 1998-02-24 | Yale University | Method of using 2-formylpyridine thiosemicarbazone compounds |
| US20030166658A1 (en) * | 2000-06-05 | 2003-09-04 | Johann Hofmann | Heterocyclic hydrazones for use as anti-cancer agents |
| MD3890G2 (en) * | 2008-09-08 | 2009-12-31 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia on base of coordinative compounds of copper(II) with salicylidene thiocarbazides |
| MD20110040A1 (en) * | 2011-05-10 | 2012-11-30 | Государственный Университет Молд0 | Inhibitors of human myeloid leukemia based on 2-[2-(pyridine-2-ilmethylidene)hydrazine]-1,3-benzothiazole and 2-[2-(1-pyridine-2-ilethylidene)hydrazine]-1,3-benzothiazole dihydrate |
| MD4215C1 (en) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide |
| MD4407B1 (en) * | 2015-04-29 | 2016-03-31 | Universitatea De Stat Din Moldova | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate |
| MD4393B1 (en) * | 2015-09-04 | 2016-01-31 | Universitatea De Stat Din Moldova | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper |
Non-Patent Citations (5)
| Title |
|---|
| Amandha KAISER DA SILVA. Complexos Heterolepticos de Ouro(III) como Potenciais Antitumorais e Anti-Trypanosoma cruzi// Dissertacao apresentada ao Instituto de Quimica de Sao Carlos. P. 31 // Sao Carlos, 2015, Data publicare: 2015-05-22, regasit la 2016.07.18, url: http://www.teses.usp.br/teses/disponiveis/75/75135/tde-20052015-154103/publico/AmandhaKaiserdaSilvarevisado.pdf pag. 31 * |
| ARORA Sh., AGARVAL Sh., SINGHAL Sh. Anticancer activities of thiosemicarbazides/thiosemicarbazones: a Review. Int. J. Pharmacy and Pharmaceutical sciences, vol. 6, Issuie 9, 2014. Regăsit în Internet la 2016.07.21, url: http://innovareacademics.in/journals/index.php/ijpps/article/view/1837 pag.1-2 * |
| D.KOVALA-DEMERTZI et al. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopical study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents. Eur. J. Med. Chem., v. 44, p. 1296-1302, 2009. Regăsit în Internet la 2016.07.20, url: https://www.researchgate.net/profile/Alexandros_Alexandratos2/publication/230792819_In_vitro_and_in_vivo_antitumor_activity_of_platinum(II)_complexes_withthiosemicarbazones_derived_from_2-formyl_and_2-acetyl_pyridine_andcontaining_ring_incorporated_at_N(4)-position_Synthesis_spectroscopicstudy_and_crystal_structure_of_platinum(II)_complexes_with_thiosemicarbazonespotential_anticancer_agents/links/0912f504724d66065a000000.pdf pag.1299, Table 4, compound (2). * |
| Kasuga N.C., Onodera K., Nakano S., Hazashi K., Nomiya K. Synthesis, crystal structures and antimicrobial activities of 6-coordinate antimony(III) complexes with tridentate 2-acetylpyridine thiosemicarbazone, bis(thiosemicarbazone) and semicarbazone ligands. J. Inorg. Biochem. 2006 July, 100, p. 1176-1186 DOI: 10.1016/j.inorbio.2006.01.037 * |
| Serda M. et al. (2014) Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships. PLOS ONE 9(10): e110291. doi: 10.1371/journal.pone.0110291. Published October 16, 2014. Regăsit în Internet la 2016.07.18 url: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110291 page 6 Figure5, chelator 1c; pag. 7 Table 1, chelator 1c * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD4434B1 (en) | 2016-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024014142A (en) | Novel small molecule inhibitors of tead transcription factors | |
| PE20181803A1 (en) | MACROCYCLIC MCL-1 INHIBITORS TO TREAT CANCER | |
| ZA202203515B (en) | Substituted pyridopyrimidinonyl compounds useful as t cell activators | |
| MX349144B (en) | SUPPRESSION OF TUMORS USING PERFUNDED HUMAN PLACENTARY AND INTERMEDIATE NATURAL DESTRUCTOR CELLS DERIVED FROM HUMAN PLACENTA. | |
| MX2018001885A (en) | Triazole derivatives, intermediates thereof and their use as fungicides. | |
| MD4194C1 (en) | Trinuclear coordinative compound tris{µ-[3,5-dibromo-2-hydroxybenzylidene-4′-(pyridin-2-yl)-thiosemicarbazido(2-)]copper}hydrate, exhibiting antifungal activity against Candida albicans | |
| UA111210C2 (en) | ANTIBACTERIAL 3,4-DIGIDRO-1H- [1,8] NAFTYRIDINONS, CYCLOPENT SUBSTITUTED [C] PYROM | |
| Suck et al. | Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies | |
| MD4434C1 (en) | Use of N'-[1-(2-pyridyl)ethylidene]morpholin-4-carbothiohydrazide as a human myeloid leukemia HL-60 cell proliferation inhibitor | |
| MX2023009677A (en) | Factor xiia inhibitors. | |
| Fairlamb et al. | η 1-2-Pyrone metal carbonyl complexes as CO-releasing molecules (CO-RMs): A delicate balance between stability and CO liberation | |
| ZA202307918B (en) | Small molecule activators of yap transcriptional activity for regenerative organ repair | |
| SOFRONOVA et al. | Liverworts of the Mus-Khaya Mountain (Yakutia, Asiatic Russia) | |
| MX2015014268A (en) | Novel triazole derivatives. | |
| Nakao et al. | Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells | |
| MD4132C1 (en) | Di(µ-S)-bis{chloro-[phenyl(pyridine-2-yl)methanone-thiosemicarbazonato(1-)]-copper} manifesting the property of inhibiting the proliferation of mammary cancer T-47D cells | |
| MX2023006231A (en) | Enzyme inhibitors. | |
| MD4407C1 (en) | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate | |
| WO2023055763A3 (en) | Small molecule inhibitors of oncogenic chd1l with preclinical activity against colorectral cancer | |
| Xiao et al. | Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate | |
| MD4190C1 (en) | Inhibitor of human myeloid leukemia based on {bis[2-(3,5-dibrom-2-hydroxyphenyl)-2-oxoethyl-piperidin-1-carbodithioato(1-)-O,O′]copper} | |
| MD4393C1 (en) | Inhibitor of human myeloid leukemia HL-60 cells based on nitrato-[N′-(1-pyridine-2-ylmethylidene)-morpholine-4-carbothiohydrazido(1-)]copper | |
| Shennara et al. | Co (II), Cu (II), Mn (II) and Ni (II) complexes of maleic hydrazide | |
| Pande et al. | Response of nitrogen application in fruit trees: A review | |
| M Vujic et al. | In vitro antitumoral activity of palladium (II) and Platinum (II) Complexes with O, O'-Dialkyl Esters of Ethylene-bis (S)-Leucine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |